Evidence map›Paper›PMID 40342393›Full record

ReviewSeminars in interventional radiology2025

Percutaneous Transesophageal Gastrostomy.

John Hufnagle, Adam Fish, Athena Masi, Jessica Lee

Abstract readReview
In one paragraph

Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John HufnagleDivision of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Adam FishDivision of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Athena MasiTouro College of Osteopathic Medicine, New York, New York.
Jessica LeeDivision of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrostomy tube placement is a well-established technique for providing long-term feeding or decompression to patients with dysphagia or the need for gastric venting. However, direct transabdominal access to the stomach is not feasible in some patients, such as those without a safe percutaneous route to the stomach, with conditions that may inhibit tract healing, and/or at high risk of peritonitis. For these patients, percutaneous transesophageal gastrostomy (PTEG) is a safe and effective technique for providing gastric access for enteral feeding or decompression. PTEG placement involves ultrasound-guided percutaneous access to the cervical esophagus using a fluid-filled balloon as a target. Since the peritoneum is not breached during PTEG placement, the risks of peritoneal spillage of enteric contents and intra-abdominal hemorrhage are avoided. However, placement requires a safe esophagostomy window and has contraindications and complications distinct from direct transabdominal access. Here, we describe the approach to patient workup and PTEG placement, present a few special situations that can be encountered, and discuss existing data regarding patient outcomes.

Indexed as

malignant bowelobstructionPTEGtransesophageal gastrostomy

Identifiers

PMID40342393
PMCPMC12058286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.